Sort
48,018 grants matching “immunotherapy”
Immunoglobulin Light Chain Fibrillogenesis
$1,599,039Boston University Medical Campus · P01 · FY2005 · HL
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
$1,599,000E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2024 · CA
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU
$1,598,938University Of Puerto Rico Med Sciences · U01 · FY2003 · AI
A system approach to targeting innate immunity in AD
$1,597,190Todd E. Golde · University Of Florida · U01 · FY2015 · AG
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
$1,596,896Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2023 · CA
Immunologic control of HIV-1 through combination bNAbs and biologics.
$1,596,752Marina Caskey · Rockefeller University · U01 · FY2023 · AI
Canine Immuno Neurotherapeutics
$1,596,668M R Chambers · University Of Alabama At Birmingham · U01 · FY2017 · CA
Enhancing T Cell Therapy of Cancer
$1,596,639Baylor College Of Medicine · P01 · FY2002 · CA
Role of microbiome in cancer and inflammation
$1,596,434Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
$1,596,329Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2022 · CA
Active Immune Therapy and HAART for HIV-1 Infection
$1,596,146University Of Pennsylvania · U19 · FY2004 · AI
Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells
$1,596,110Carl H. June · University Of Pennsylvania · U19 · FY2013 · AI
Methamphetamine Abuse Research Center
$1,595,931Aaron J. Janowsky · Oregon Health & Science University · P50 · FY2012 · DA
Human Mab Cocktails to Prevent & Treat H5N1 Avian Influenza
$1,594,408Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2007 · AI
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,593,930Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$1,593,930Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
A system approach to targeting innate immunity in AD
$1,592,165Todd E. Golde · University Of Florida · U01 · FY2016 · AG
ADULT AIDS CLINICAL TRIALS UNIT
$1,591,480University Of Washington · U01 · FY2004 · AI
Multiscale Analysis of Immune Responses
$1,590,437Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
TOSB Surgical Oncology Fellowship Program
$1,588,556David Schrump · Division Of Basic Sciences - Nci · ZIE · FY2018 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$1,588,110University Of Pittsburgh At Pittsburgh · U01 · FY2004 · AI
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,586,326Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Understanding and Altering the Virologic Setpoint
$1,582,060Aaron Diamond Aids Research Center · U01 · FY2003 · AI
Radiation-induced molecular targets
$1,581,677Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Vaccines, Immunoprophylaxis, and Immunotherapy for SARS
$1,581,212Kanta Subbarao · Niaid Extramural Activities · Z01 · FY2007 · AI